Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
IS18 - Symposium by MSD: Redefining Survival Expectations In Lung Cancer (Not IASLC CME Accredited)
- 13:00 - 14:30
- 9/10/2019
- Location: Barcelona (2005)
- Type: Industry Symposia & Workshops
- Track:
-
+
ES25 - Liquid Biopsy
- 14:30 - 16:00
- 9/10/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Educational Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Max Diehn, Lucia Milla Collado
-
+
ES25.01 - Liquid Biopsy: State of the Science
14:30 - 14:50 | Presenter: Eloisa Jantus-Lewintre
- Abstract
Loading... -
+
ES25.02 - Liquid Biopsy: Utility for Surveillance in Early Stage
14:50 - 15:10 | Presenter: Lecia Sequist
- Abstract
No abstract available for this presentation
-
+
ES25.03 - Leveraging the Quantitative Nature of Cfdna Genotyping for Lung Cancer Care
15:10 - 15:30 | Presenter: Cloud P Paweletz
- Abstract
Loading... -
+
ES25.04 - Liquid Biopsy: Utility for Early Detection
15:30 - 15:50 | Presenter: Ana Vivancos
- Abstract
Loading... -
+
ES25.05 - Q&A
15:50 - 16:00
- Abstract
No abstract available for this presentation
-
+
ES26 - The Impact of Specialist Nursing and Allied Health Professionals in the Care of Thoracic Oncology Patients
- 14:30 - 15:45
- 9/10/2019
- Location: San Francisco (2009)
- IASLC CME Accredited
- Type: Educational Session
- Track: Nursing and Allied Professionals
- Moderators:Pippa Labuc, Enza Esposito Nguyen
-
+
ES26.01 - The Impact of Specialist Nursing Intervention in Lung Cancer
14:30 - 14:45 | Presenter: Alison Leary
- Abstract
Loading... -
+
ES26.02 - Rehabilitation After Treatment of Thoracic Malignancies
14:45 - 15:00 | Presenter: Chris L Wells
- Abstract
Loading... -
+
ES26.03 - The Impact of Early Nursing Intervention on Outcomes for Thoracic Oncology Patients
15:00 - 15:15 | Presenter: Iveta Nohavova
- Abstract
Loading... -
+
ES26.04 - Early Intervention and Rehabilitation for Patients Newly Diagnosed with Thoracic Malignancies
15:15 - 15:30 | Presenter: Morten Quist
- Abstract
Loading... -
+
ES26.05 - Q&A
15:30 - 15:45
- Abstract
No abstract available for this presentation
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.01 - Generation and Characterization of Novel Preclinical Disease Models of NSCLC with NRG1 Rearrangements to Improve Therapy
14:30 - 14:35 | Presenter: Eric Gladstone | Author(s): Morana Vojnic, Michael Offin, Lukas Delasos, Allan J. W. Lui, Evan Siau, Hirko Sato, Ryma Benayed, Renate Kurth, Marissa Mattar, Inna Khodos, Elisa De Stanchina, Robert Daly, Alison Schram, Alexander Drilon, Marc Ladanyi, Romel Somwar
- Abstract
Loading... -
+
MA21.02 - Genomic Origin and EGFR-TKI Efficacy of Pulmonary Adenosquamous Carcinoma
14:35 - 14:40 | Presenter: Gen Lin | Author(s): Chao Li, Pansong Li, Wenzhang Fang, Haipeng Xu, Yuhua Gong, Zhengfei Zhu, Yi Hu, Wenhua Liang, Qian Chu, Wen-Zhao Zhong, Lin Wu, Huijuan Wang, Zhijie Wang, Ziming Li, Jie Lin, Yan-Fang Guan, Xuefeng Xia, Xin Yi, Qian Miao, Biao Wu, Kang Jiang, Xiaobin Zheng, Weifeng Zhu, Xinlong Zheng, Huang Peisha, Xiao Wenjin, Dan Hu, Longfeng Zhang, Xirong Fan, Tony Mok, Cheng Huang
- Abstract
Loading... -
+
MA21.03 - The International Association for the Study of Lung Cancer (IASLC) Global Survey on Molecular Testing in Lung Cancer
14:40 - 14:45 | Presenter: Matthew P Smeltzer | Author(s): Murry W Wynes, Meghan Taylor, Kristin Richeimer, Kelsey Wood, Kristen Howell, Mercedes Liliana Dalurzo, Enriqueta Felip, Keith Kerr, Edward Kim, Sylvie Lantuejoul, Clarissa Mathias, Pieter E. Postmus, Charles Powell, Suresh S Ramalingam, Ross Soo, Masahiro Tsuboi, Ignacio Wistuba, Marileila Varella-Garcia, Giorgio Vittorio Scagliotti, Fred R. Hirsch
- Abstract
Loading... -
+
MA21.04 - Discussant - MA21.01, MA21.02, MA21.03
14:45 - 15:00 | Presenter: Michael Duruisseaux
- Abstract
No abstract available for this presentation
-
+
MA21.05 - Phase II Trial of the Combination of Alectinib with Bevacizumab in ALK-Positive Nonsquamous Non-Small Cell Lung Cancer
15:00 - 15:05 | Presenter: Satoshi Watanabe | Author(s): Naoya Matsumoto, Jun Koshio, Akane Ishida, Tomohiro Tanaka, Tetsuya Abe, Daisuke Ishikawa, Satoshi Shoji, Koichiro Nozaki, Kosuke Ichikawa, Rie Kondo, Aya Otsubo, Ami Aoki, Tomosue Kajiwara, KENICHI Koyama, Satoru Miura, Hirohisa Yoshizawa, Toshiaki Kikuchi
- Abstract
Loading... -
+
MA21.06 - Preliminary Phase 1 Results of U3-1402 — A Novel HER3-Targeted Antibody–Drug Conjugate—in EGFR TKI-Resistant, EGFR-Mutant NSCLC
15:05 - 15:10 | Presenter: Helena A Yu | Author(s): Melissa Johnson, Conor E Steuer, Michele Vigliotti, Shuquan Chen, Yasuki Kamai, Channing Yu, Pasi A Jänne
- Abstract
Loading... -
+
MA21.07 - Circulating Tumor DNA Analysis Depicts Potential Mechanisms of Resistance to BRAF-Targeted Therapies in BRAF+ Non-Small Cell Lung Cancer
15:10 - 15:15 | Presenter: Sandra Ortiz-Cuaran | Author(s): Laura Mezquita, Aurélie Swalduz, Mihaela Aldea, Julien Mazieres, CECILE Jovelet, Washington René Chumbi Flores, LUDOVIC Lacroix, Yohan Loriot, Luc Friboulet, Virginie Westeel, Maud Ngocamus, Anne Pradines, Claire Tissot, Christelle Clement Duchene, Christine Raynaud, Xavier Quantin, Radj Gervais, Etienne Brain, Isabelle Monnet, Etienne Giroux Leprieur, Virginie Avrillon, Céline Mahier-Aït Oukhatar, Natalie Hoog-Labouret, Frank De Kievit, Karen Howarth, Jean-Francois Guichou, Clive Morris, Emma Green, Maurice Perol, Benjamin Besse, Jean-Yves Blay, Pierre Saintigny, David Planchard
- Abstract
Loading... -
+
MA21.08 - Discussant - MA21.05, MA21.06, MA21.07
15:15 - 15:30 | Presenter: Toyoaki Hida
- Abstract
No abstract available for this presentation
-
+
MA21.09 - Tyrosine Kinase Inhibitors' Plasma Concentration and Oncogene-Addicted Advanced Non-Small Lung Cancer (aNSCLC) Resistance
15:30 - 15:35 | Presenter: Arthur Geraud | Author(s): Laura Mezquita, Edouard Auclin, David Combarel, JULIA Delahousse, CHARLES Naltet, CECILE Jovelet, pernelle Lavaud, Anas Gazzah, LUDOVIC Lacroix, Jordi Remon, CAROLINE Caramella, David Planchard, OLIVIER Mir, ANGELO Paci, Benjamin Besse
- Abstract
Loading... -
+
MA21.10 - Phase II Study of 160mg of Osimertinib in EGFR T790M Positive NSCLC with Brain or Leptomeningeal Metastases Who Progressed on Prior EGFR TKI
15:35 - 15:40 | Presenter: Myung-Ju Ahn | Author(s): Sehhoon Park, Sunyoung Hong, JuYoun Park, MI RA Park, Hyun Ae Jung, Jong-Mu Sun, Se-Hoon Lee, Jin Seok Ahn, Keunchil Park
- Abstract
Loading... -
+
MA21.11 - A Multicenter Phase II Study of Low-Dose Erlotinib in Frail Patients with EGFR Mutation-Positive, Non-Small Cell Lung Cancer: TORG1425
15:40 - 15:45 | Presenter: Sakiko Otani | Author(s): Kazuhiko Yamada, Shingo Miyamoto, Koichi Azuma, Hidenobu Ishii, Akihiro Bessho, Shinobu Hosokawa, Hideo Kunitoh, Kazuhito Miyazaki, Hiroshi Tanaka, Satoru Miura, Hiromi Aono, Yoshiro Nakahara, Kei Kusaka, Yukio Hosomi, Akinobu Hamada, Hiroaki Okamoto
- Abstract
Loading... -
+
MA21.12 - Discussant - MA21.09, MA21.10, MA21.11
15:45 - 16:00 | Presenter: Hong-Xu Liu
- Abstract
No abstract available for this presentation
-
+
MA23 - Preclinical Models and Genetics of Malignant Pleural Mesothelioma
- 14:30 - 16:00
- 9/10/2019
- Location: Copenhagen (1980)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Mesothelioma
- Moderators:Ramon Palmero Sánchez, Raphael Bueno
-
+
MA23.01 - Phase II Trial of an Oral FGFR Inhibitor AZD4547 as Second or Third Line Therapy in Malignant Pleural Mesothelioma: Final Results of FRAME Study
14:30 - 14:35 | Presenter: Wei-Sen Lam | Author(s): Anna K Nowak, Fred Chen, Sanjeevan Muruganandan, Sukyana Arunachalam, Melvin Chin, Michael Millward, Cathy Read, Kevin Murray, Jenette Creaney, Y C Gary Lee
- Abstract
Loading... -
+
MA23.02 - CDK4/6 Inhibitors Show Antitumor Effects in Preclinical Models of Malignant Pleural Mesothelioma
14:35 - 14:40 | Presenter: Elisabeth Aliagas | Author(s): Maria Martínez-Iniesta, Miguel Hernández, Ania Alay, David Cordero, Xavier Solé, Francisco Rivas, Anna Ureña, Noelia Vilariño, Cristina Muñoz-Pinedo, Alberto Villanueva, Ernest Nadal
- Abstract
Loading... -
+
MA23.03 - BAP1 Loss Induces Genome Instability Through BRCA1-Dependent and Independent Mechanisms in Mesothelioma
14:40 - 14:45 | Presenter: Anita Singh
- Abstract
Loading... -
+
MA23.04 - Discussant - MA23.01, MA23.02, MA23.03
14:45 - 15:00 | Presenter: Nobukazu Fujimoto
- Abstract
No abstract available for this presentation
-
+
MA23.05 - A Phase II Trial of Nintedanib in Recurrent Malignant Pleural Mesothelioma (MPM)
15:00 - 15:05 | Presenter: Antoinette Josephine Wozniak | Author(s): Bryan J. Schneider, Gregory Kalemkerian, Robert Daly, Wei Chen, Jaclyn Ventimiglia, Misako Nagasaka, Marjorie Zauderer
- Abstract
Loading... -
+
MA23.06 - Development of a Novel Genetically Engineered Mouse Model of Malignant Pleural Mesothelioma
15:05 - 15:10 | Presenter: Katarina Gyuraszova | Author(s): Tiziana Monteverde, Tatyana Chernova, Rodger Duffin, Kevin Blyth, Anton Berns, Marion Macfarlane, Daniel J. Murphy
- Abstract
Loading... -
+
MA23.07 - Loss of Expression of BAP1 and/or MTAP Aids in the Diagnosis of Malignant Mesothelioma Metastatic to Lymph Nodes
15:10 - 15:15 | Presenter: Anja C. Roden | Author(s): Tobias Peikert, Julie Vrana, Angela Hudson, Dennis Wigle, Marie Christine Aubry, Aaron S. Mansfield
- Abstract
Loading... -
+
MA23.08 - Discussant - MA23.05, MA23.06, MA23.07
15:15 - 15:30 | Presenter: Kemp Kernstine
- Abstract
No abstract available for this presentation
-
+
MA23.09 - Fusion Genes Identified from Whole Genome and Whole Transcriptome Sequencing of Malignant Pleural Mesothelioma Tumours
15:30 - 15:35 | Presenter: Tian Mun Chee | Author(s): Harald Oey, Kwun M Fong, Ian Yang, Lutz Krause, Rayleen Bowman
- Abstract
Loading... -
+
MA23.10 - Low Number of Mutations and Frequent Co-Deletions of CDKN2A and IFN Type I Characterize Malignant Pleural Mesothelioma
15:35 - 15:40 | Presenter: Anca Mihaela Nastase | Author(s): Amit Mandal, Shir Kiong Lu, Spyridon Gennatas, Hima Anbunathan, Matthew Edwards, Deborah Morris-Rosendahl, Anthony Newman Taylor, Robert C Rintoul, Eric Lim, Sanjay Popat, Andrew G Nicholson, Mark Lathrop, Anne M Bowcock, Miriam F Moffatt, William O.C Cookson
- Abstract
Loading... -
+
MA23.11 - Analysis of Immune Phenotype Composition in Malignant Pleural Mesothelioma (MPM) Using Bulk RNA Sequencing
15:40 - 15:45 | Presenter: Amit Mandal | Author(s): Anca Mihaela Nastase, Shir Kiong Lu, Spyridon Gennatas, Hima Anbunathan, Matthew Edwards, Deborah Morris-Rosendahl, Anthony Newman Taylor, Robert C Rintoul, Eric Lim, Sanjay Popat, Andrew G Nicholson, Anne M Bowcock, Mark Lathrop, Miriam F Moffatt, William O.C Cookson
- Abstract
Loading... -
+
MA23.12 - Discussant - MA23.09, MA23.10, MA23.11
15:45 - 16:00 | Presenter: Kenneth John O’Byrne
- Abstract
No abstract available for this presentation
-
+
MA24 - Initiatives to Improve Health in Lung Cancer Patients
- 14:30 - 16:00
- 9/10/2019
- Location: Melbourne (1991)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advocacy
- Moderators:Merel N. Mountain, Nicoleta Mitrea
-
+
MA24.01 - Challenges in Lung Cancer Clinical Trials: A European Perspective
14:30 - 14:35 | Presenter: Anne-Marie Baird | Author(s): Diego Villalón, Alfonso Aguarón, Christian Smitt-Plank, Tommy Björk, Regine Deniel Ihlen, Ewelina Szmytke, Stefania Vallone
- Abstract
Loading... -
+
MA24.02 - Developing Regional Activity for a National Charity: The Lung Cancer Canada Experience
14:35 - 14:40 | Presenter: Paul Wheatley-Price | Author(s): Paul Robertson, Michelle Brennan, Jill Hamer-Wilson, Andrea Redway, Mariel Bouris, Diane Manii, Jacques Ricard, Shem Singh
- Abstract
Loading... -
+
MA24.03 - Factors Impacting Patients’ Worries (Accessing Treatment, Treatment Toxicity, & Emotional Burden) Associated with Lung Cancer Treatments
14:40 - 14:45 | Presenter: Andrea S Ferris | Author(s): Upal Basu Roy, Sarah A Janse, Ellen M Janssen, Alexa Meara, Carolyn J Presley, Peter J Kneuertz, John FP Bridges
- Abstract
Loading... -
+
MA24.04 - Discussant - MA24.01, MA24.02, MA24.03
14:45 - 15:00 | Presenter: Deb Whippen
- Abstract
No abstract available for this presentation
-
+
MA24.05 - Lung Cancer in Europe: Strengthening Policy Responses One Country at a Time
15:00 - 15:05 | Presenter: Mary E Bussell | Author(s): Alan D Lovell
- Abstract
Loading... -
+
MA24.06 - Using Global Data as an Advocacy Tool – The Global Lung Cancer Coalition’s E-Atlas of Lung Cancer
15:05 - 15:10 | Presenter: Winfield Boerckel | Author(s): Sarah Elizabeth Winstone, Maureen Rigney, Jesme Fox, Peter Horton-Fawkes
- Abstract
Loading... -
+
MA24.07 - Impact of Radiologist Recommendations on Timeliness of Lung Cancer Referral: Baseline Data to Guide a Quality Improvement Initiative
15:10 - 15:15 | Presenter: Monica Lynn Laginha Mullin | Author(s): Thomas Howard, Gurmohan Rob Dhillon, Genevieve C Digby
- Abstract
Loading... -
+
MA24.08 - Discussant - MA24.05, MA24.06, MA24.07
15:15 - 15:30 | Presenter: Merel N. Mountain
- Abstract
No abstract available for this presentation
-
+
MA24.09 - Stigma in Early Stage Lung Cancer
15:30 - 15:35 | Presenter: Eric LR Bedard | Author(s): Jessica Culling, Sarah Bedard, Simon R Turner, S Johnson, Janelle Pellizzari
- Abstract
Loading... -
+
MA24.10 - Estimation of Deaths Due to Lack of Access to Immunotherapy for Brazilian Patients Diagnosed with Advanced NSCLC Without Any Driver Mutation
15:35 - 15:40 | Presenter: Vinicius Knackfuss Goncalves | Author(s): Vinicius Lorandi, Stephen Doral Stefani, Leonardo Paludo, Rafaela Kirchner Piccoli
- Abstract
Loading... -
+
MA24.11 - A Project to Control Passive Smoking by Lung Cancer Patients "Don't Smoke Near Me! Don't Be Like Me!"
15:40 - 15:45 | Presenter: Kazuo Hasegawa | Author(s): Hiroko Saito, FUsayo Miyake, Chigusa Nakamura, Yuko Tanaka, Tomomi Ito, Seiko Inaba, Chikako Endo, Koji Onishi, Masayo Onishi, Nobuyuki Kishimoto, Yuko Komatsu, Isamu Tanaka, Makiko Tanaka, Takehiko Hatsuda
- Abstract
Loading... -
+
MA24.12 - Discussant - MA24.09, MA24.10, MA24.11
15:45 - 16:00 | Presenter: Bonnie Addario
- Abstract
No abstract available for this presentation
-
+
MA25 - Precision Medicine in Advanced NSCLC
- 14:30 - 16:00
- 9/10/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Sebastian Defranchi, Karen Kelly
-
+
MA25.01 - Pembrolizumab Plus Chemotherapy for Advanced NSCLC Without Tumor PD-L1 Expression: Pooled Analysis of KN021G, KN189 and KN407
14:30 - 14:37 | Presenter: Hossein Borghaei | Author(s): Corey Jay Langer, Luis Paz-Ares, Delvys Rodriguez Abreu, Balazs Halmos, Vassiliki A Papadimitrakopoulou, Marina Chiara Garassino, Baerin Houghton, Takayasu Kurata, Ying Cheng, Jianxin Lin, M. Catherine Pietanza, Bilal Piperdi, Shirish Gadgeel
- Abstract
Loading... -
+
MA25.02 - Arrangement and Architecture of Tumor-Infiltrating Lymphocyte on H&E Slides Predict OS in Nivolumab Treated Non-Small Cell Lung Cancer
14:37 - 14:44 | Presenter: Kaustav Bera | Author(s): Xiangxue Wang, Cristian Barrera, Cheng Lu, Michael Feldman, Kurt A Schalper, David Rimm, Vamsidhar Velcheti, Anant Madabhushi
- Abstract
Loading... -
+
MA25.03 - Tumor-Infiltrating Lymphocytes (TIL) and Outcomes with Immunotherapy (ICI) or Chemotherapy in Advanced NSCLC (aNSCLC) Patients
14:44 - 14:51 | Presenter: Julien Adam | Author(s): Laura Mezquita, Ithar Gataa, Caroline Rossoni, Edouard Auclin, Myriam Kossai, Frank Aboubakar, Sylvestre Le Moulec, Julie Massé, Morgane Masson, Nina Radosevic-Robin, Mathieu Rouanne, Maria Virginia Bluthgen, CAROLINE Caramella, Lizza Hendriks, Anas Gazzah, David Planchard, Jean-Pierre Pignon, Benjamin Besse
- Abstract
Loading... -
+
MA25.04 - Blood-Based Tumor Mutation Burden as a Predictive Biomarker for Outcomes After Pembrolizumab Based First Line Therapy in Metastatic NSCLC
14:51 - 14:58 | Presenter: Charu Aggarwal | Author(s): Jeffrey C Thompson, Austin Chien, Katie Quinn, Martina I. Lefterova, Rebecca Nagy, Stephanie S Yee, Michael Lariviere, Christine Ciunci, Aditi Singh, Joshua M Bauml, Roger B Cohen, Corey Jay Langer, Erica Carpenter
- Abstract
Loading... -
+
MA25.05 - Discussant - MA25.01, MA25.02, MA25.03, MA25.04
14:58 - 15:08 | Presenter: Karen Kelly
- Abstract
No abstract available for this presentation
-
+
MA25.06 - Q&A Session
15:08 - 15:15
- Abstract
No abstract available for this presentation
-
+
MA25.07 - Genomic Profiling of Lung Adenocarcinoma by Targeted NGS Using Extracellular Vesicle-Derived DNA in Bronchoalveolar Lavage Fluid
15:15 - 15:22 | Presenter: Seungeun Lee | Author(s): Kye Young Lee, Jae Young Hur, Heejoung Kim, Wan Seop Kim, In Ae Kim, Ha Young Park
- Abstract
Loading... -
+
MA25.08 - Characterisation of Tumor Aetiology Using Mutational Signatures from the Non-Small Cell Lung Cancer Genome
15:22 - 15:29 | Presenter: Colin Lindsay | Author(s): Shereen Rafee, Pantelis Nicola, Andrew Wallace, George Burghel, Helene Schlecht, Katie Baker, Eleanor Baker, Lynsey Priest, Jane Rogan, Sharzad Moghadam, Mat Carter, William Newman, Fiona Blackhall
- Abstract
Loading... -
+
MA25.09 - Navigating Anlotinib Precision Therapy Through the Genetic Profiling of Circulating DNA in Non-Small Cell Lung Cancer Patients
15:29 - 15:36 | Presenter: Jun Lu | Author(s): Hua Zhong, Jun Wu, Tianqing Chu, Lele Zhang, Hua Li, Qiming Wang, Rong Li, Yizhuo Zhao, Aiqin Gu, Chunlei Shi, Liwen Xiong, Xueyan Zhang, Wei Zhang, Yuqing Lou, Bo Yan, Yu Dong, Yanwei Zhang, Baolan Li, Li Zhang, Xiaodong Zhao, Kai Li, Baohui Han
- Abstract
Loading... -
+
MA25.10 - First-In-Human Phase 1 Study of DS-1062a (TROP2 Antibody-Drug Conjugate) in Patients with Advanced Non-Small Cell Lung Cancer
15:36 - 15:43 | Presenter: Rebecca S Heist | Author(s): Jacob Sands, Toshio Shimizu, Edward Garon, Antoine Yver, Jonathan Greenberg, Penny Phillips, Yukata Noguchi, Alexander Spira, Noboru Yamamoto, Melissa Johnson, Funda Meric-Bernstam, Kiyotaka Yoh, Aaron Lisberg
- Abstract
Loading... -
+
MA25.11 - Discussant - MA25.07, MA25.08, MA25.09, MA25.10
15:43 - 15:53 | Presenter: Sebastian Defranchi
- Abstract
No abstract available for this presentation
-
+
MA25.12 - Q&A Session
15:53 - 16:00
- Abstract
No abstract available for this presentation
-
+
MS16 - The Interventional Pulmonologist's Contribution to Screen-Detected Nodules: From Diagnosis to Treatment
- 14:30 - 16:00
- 9/10/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Interventional Diagnostics/Pulmonology
- Moderators:Luc Thiberville, Kazuhiro Yasufuku
-
+
MS16.01 - Getting to the Target: Transparenchimal Approaches
14:30 - 14:40 | Presenter: Daniela Gompelmann
- Abstract
Loading... -
+
MS16.02 - Robotic Bronchoscopy: Driveless IP?
14:40 - 14:50 | Presenter: David Fielding
- Abstract
Loading... -
+
MS16.03 - Bronchoscopy and Optical Biopsy
14:50 - 15:00 | Presenter: Lizzy Wijmans
- Abstract
Loading... -
+
MS16.04 - Bronchoscopic Lung Cancer Ablation
15:00 - 15:10 | Presenter: Kazuhiro Yasufuku
- Abstract
Loading... -
+
MS16.05 - Optimal Treatment Selection for Screen-Detected Lung Cancers
15:10 - 15:20 | Presenter: Norihiko Ikeda
- Abstract
Loading... -
+
MS16.06 - Smoking Cessation in a Pulmonary Clinic
15:20 - 15:30 | Presenter: Pyng Lee
- Abstract
Loading... -
+
MS16.07 - Q&A
15:30 - 16:00
- Abstract
No abstract available for this presentation
-
+
MS17 - Pathology of the Future
- 14:30 - 16:00
- 9/10/2019
- Location: Interlaken (1988)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Pathology
- Moderators:Erik Thunnissen, Teh-Ying Chou
-
+
MS17.01 - Role of Liquid Biopsy in the Pathology Diagnosis Workflow (Including DNA, RNA Ad Exosomes)
14:30 - 14:45 | Presenter: Fernando Lopez-Rios
- Abstract
Loading... -
+
MS17.02 - Major Pathological Evaluation in Neoadjuvant Immunotherapy
14:45 - 15:00 | Presenter: Jose Ramirez
- Abstract
Loading... -
+
MS17.03 - Quantitative Image Analysis, Image-Based Profiling Including 3D Digital Printing and AI
15:00 - 15:15 | Presenter: Sylvie Lantuejoul
- Abstract
Loading... -
+
MS17.04 - Multiplex Immunohistochemistry
15:15 - 15:30 | Presenter: Ignacio Wistuba | Author(s): Edwin Parra, Alejandro Francisco Cruz
- Abstract
Loading... -
+
MS17.05 - Controversies in Pathologic Staging
15:30 - 15:45 | Presenter: Masaya Yotsukura
- Abstract
Loading... -
+
MS17.06 - Q&A
15:45 - 16:00
- Abstract
No abstract available for this presentation
-
+
MS18 - Role of Biomarkers in Lung Cancer Screening
- 14:30 - 16:00
- 9/10/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Symposium
- Track: Screening and Early Detection
- Moderators:Luis M Montuenga, Luis M Seijo
-
+
MS18.01 - Exhaled Breath Biomarkers
14:30 - 14:40 | Presenter: Nir Peled
- Abstract
Loading... -
+
MS18.02 - Circulating Nucleic Acid Biomarkers
14:40 - 14:50 | Presenter: Gabriella Sozzi | Author(s): Mattia Boeri, Ugo Pastorino
- Abstract
Loading... -
+
MS18.03 - Amolecular Diagnostics, Incorporating GWAS and Risk Models: Future Approaches to the Identification of High-Risk Individuals
14:50 - 15:00 | Presenter: Paul Brennan | Author(s): Christopher Ian Amos
- Abstract
Loading... -
+
MS18.04 - Alternative and Promising Biomarkers
15:00 - 15:10 | Presenter: Ruben Pio
- Abstract
Loading... -
+
MS18.05 - Sputum Biomarkers, Dysplasia and Chemoprevention
15:10 - 15:20 | Presenter: Robert L. Keith
- Abstract
Loading... -
+
MS18.06 - Captive Audience, Teachable Moment - Integrating Tobacco Cessation in Lung Cancer Screening
15:20 - 15:30 | Presenter: Martin Tammemagi
- Abstract
Loading... -
+
MS18.07 - Q&A
15:30 - 16:00
- Abstract
No abstract available for this presentation